STAT

Opinion: The economic rationale for strong action now against Covid-19

Although the economic costs of combating #Covid19 epidemic are already large and mounting, now is the time to use the U.S.'s immense resources to contain the disease and mitigate its…
Traders work during the opening bell at the New York Stock Exchange Monday. Trading on Wall Street was halted immediately after the opening bell Monday, as stocks posted steep losses following emergency moves by the Federal Reserve to try to avert a recession due to the coronavirus pandemic.

As governments and communities struggle to figure out the best way to deal with the novel coronavirus, a major concern is how to balance the risk to lives versus the risk to livelihoods. In short, how do we balance the public health versus economic consequences of this pandemic?

The answer comes from a widely used economic tool, and it is telling us that extreme measures are warranted.

It is difficult to (VSL) to think about the trade-off between the risk of dying and money. For example, how much more are you willing to pay for upgraded safety features on a car?

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

Related Books & Audiobooks